Biblio

Export 629 results:
Author [ Keyword(Desc)] Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Humans
J. Wang, Tan, L., and Yu, J. - T., Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives., J Alzheimers Dis, vol. 50, no. 4, pp. 927-45, 2016.
E. L. Ashby, Miners, J. S., Kehoe, P. G., and Love, S., Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex., J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.
N. - Y. Jung, Han, C. E., Kim, H. Jin, Yoo, S. Wook, Kim, H. - J., Kim, E. - J., Na, D. L., Lockhart, S. N., Jagust, W. J., Seong, J. - K., and Seo, S. Won, Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 1125-35, 2016.
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study., J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
M. Frenkel-Pinter, Tal, S., Scherzer-Attali, R., Abu-Hussien, M., Alyagor, I., Eisenbaum, T., Gazit, E., and Segal, D., Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity., J Alzheimers Dis, vol. 51, no. 1, pp. 165-78, 2016.
P. Chatterjee, Lim, W. L. F., Shui, G., Gupta, V. B., James, I., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., Benzinger, T., Masters, C., Snowden, S. G., Wenk, M. R., Bateman, R. J., Morris, J. C., and Martins, R. N., Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study., J Alzheimers Dis, vol. 50, no. 3, pp. 887-94, 2016.
E. Niemantsverdriet, Goossens, J., Struyfs, H., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Vanderstichele, H., and Engelborghs, S., Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
Y. Zhang, Wang, S., Phillips, P., Yang, J., and Yuan, T. - F., Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 1163-79, 2016.
X. Luo, Qiu, T., Xu, X., Huang, P., Gu, Q., Shen, Z., Yu, X., Jia, Y. L., Guan, X., Song, R., and Zhang, M., Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study., J Alzheimers Dis, vol. 50, no. 4, pp. 1137-48, 2016.
Y. Manso, Comes, G., López-Ramos, J. C., Belfiore, M., Molinero, A., Giralt, M., Carrasco, J., Adlard, P. A., Bush, A. I., Delgado-García, J. María, and Hidalgo, J., Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
A. K. Tripathi and Singh, N., Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 107-21, 2016.
R. A. Mudar, Chiang, H. - S., Eroh, J., Nguyen, L. T., Maguire, M. J., Spence, J. S., Kung, F., Kraut, M. A., and Hart, J., The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials., J Alzheimers Dis, vol. 50, no. 2, pp. 577-90, 2016.
E. Makovac, Serra, L., Spanò, B., Giulietti, G., Torso, M., Cercignani, M., Caltagirone, C., and Bozzali, M., Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 591-604, 2016.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up., J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
M. Lacalle-Aurioles, Navas-Sánchez, F. Javier, Alemán-Gómez, Y., Olazarán, J., Guzmán-De-Villoria, J. Adán, Cruz-Orduña, I., Mateos-Pérez, J. María, and Desco, M., The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging., J Alzheimers Dis, vol. 50, no. 4, pp. 1051-64, 2016.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E., Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial., J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
M. W. Granger, Franko, B., Taylor, M. W., Messier, C., St George-Hyslop, P., and Bennett, S. A. L., A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve., J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
H. K. Mohseni and Chettle, D. R., A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects., J Alzheimers Dis, vol. 50, no. 4, pp. 913-26, 2016.
J. Kida, Nemoto, K., Ikejima, C., Bun, S., Kakuma, T., Mizukami, K., and Asada, T., Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study., J Alzheimers Dis, vol. 51, no. 2, pp. 405-15, 2016.
A. Pilotto, Turrone, R., Liepelt-Scarfone, I., Bianchi, M., Poli, L., Borroni, B., Alberici, A., Premi, E., Formenti, A., Bigni, B., Cosseddu, M., Cottini, E., Berg, D., and Padovani, A., Vascular Risk Factors and Cognition in Parkinson's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 563-70, 2016.
W. Wruck, Schröter, F., and Adjaye, J., Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks., J Alzheimers Dis, vol. 50, no. 4, pp. 1065-82, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L., miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling., J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology., J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.

Pages